ESCMID Global 2025

April 12, 2025 - April 15, 2025

Messe Wien Exhibition & Congress Center | Vienna, Austria

Our health is all connected: 

Driving the One Health approach at Booth #B54 in Vienna

Discover a range of innovative solutions to address major health challenges across sectors, including the emergence of infectious diseases, antimicrobial resistance and environmental surveillance at ESCMID Global 2025. 

 

At Thermo Fisher Scientific, we work across disciplines to ensure a holistic approach to health, including human, animal and environmental applications, while offering unparalleled support and expertise. Learn more about how we can help you achieve your goals with our advanced solutions, including:

Helping to battle AMR and guiding the best therapeutic decisions with definitive MIC results and the latest antimicrobials for antimicrobial susceptibility testing (AST), combined with over 100 years of culture media expertise.

Growing your testing capabilities with advanced molecular testing solutions for pathogen detection and antimicrobial resistance profiling. Our real-time PCR and digital PCR technologies enable early and accurate pathogen detection from a large variety of samples, crucial for monitoring emerging threats.

Whether you are a test developer or a researcher, you will need access to high-quality raw materials and secure supply chains for assay development with Custom Commercial Supply. Our team is here to help you speed up your development and bring your solutions to market faster.


Register for our Innovation & Pipeline Theater and on-booth events

Isothermal Recombinase Polymerase (RPA) reagents for diagnostic assay development and research

 

Sunday, April 13th, 10:00-10:20 AM

 

Speaker: Agnė Alminaitė, PhD, Product Manager, Molecular Biology, Custom Commercial Supply, Thermo Fisher Scientific

 

Location: Innovation and Pipeline Theater

 

The RPA method requires minimal technical expertise and equipment, making it accessible for use in various settings. The robustness and efficiency of the RPA reaction is advantageous not only in the molecular diagnostics market, addressing the growing demand for rapid, reliable, and cost-effective DNA amplification methods, but also as an alternative to PCR in NGS library preparation steps.

 

Recombinase Polymerase Amplification (RPA) is a novel isothermal DNA amplification technique that operates at a constant low temperature (37-45 °C) with only two specific primers, offering a rapid and sensitive alternative to traditional temperature cycling requiring methods like PCR. High reaction temperatures not only require complex equipment but can damage fragile, scarce, fragmented samples. Therefore, RPA is a cost, energy, and sample saving option for nucleic acid amplification. It can be adapted in resource-limited settings and decentralized diagnostics applications.  

 

We developed RPA reagents compatible with lyophilization. Additionally, the RPA reaction conditions were optimized and the composition of the RPA reaction buffer adapted to ensure consistent and reliable results across diverse sample types. Moreover, we demonstrated the use of RPA reaction as a low temperature NGS library preamplification option.

From Dysbiosis to Detection: Exploring the Impact of Vaginal Microbiome Testing on Reproductive Success

 

Sunday, April 13th, 11:30-11:50 AM

 

Speaker: Dr. Arne Materna, Co-CEO and member of Board of Directors, Bio-Me AS                                                                                

 

Location: Innovation and Pipeline Theater

 

Infertility affects one in six couples, with fertility treatments facing daunting 2:1 odds of failure versus success. Emerging research highlights the critical role of vaginal microbiome health in reproductive outcomes. Dysbiosis and other microbiological conditions of the female genitourinary system have been strongly linked to poor fertility outcomes. However, routine infertility care is hindered by the lack of standardized tools for microbiome characterization. Current standard of care tests are not suitable for microbiome profiling, and common approaches for microbiome analysis, such as sequencing, face significant technical limitations when applied to vaginal specimens.

 

This presentation reviews key studies connecting vaginal microbiome health to fertility outcomes and examines the technical barriers to vaginal microbiome analysis. It introduces PMP™, a precision microbiome profiling method utilizing highly parallelized single-plex quantitative PCR, and discusses its potential for routine use in infertility care, including applications in blended care models.


Epidemiological outlook of the 2024 Bordetella pertussis outbreak in Austria: Trends, challenges, and public health implications

 

Monday, April 14th, 12:15 PM

 

Speaker: Priv.-Doz. Dr. Daniela Schmid, MSc, Head of the Department of Infection Diagnostics and Infection Epidemiology at the Medical University of Vienna

 

Location: Booth #B54

 

PCR diagnostics of Bordetella pertussis and Bordetella parapertussis in Austria: Trends and insights from 2024

 

Monday, April 14th, 12:35 PM

 

Speaker: Donna Simeoni, MSc, Head of Molecular Infection Diagnostics at the Department of Infection Diagnostics and Infection Epidemiology at the Medical University of Vienna

 

Location: Booth #B54

 


From Sewage to Safety: Digital PCR's Role in Tracking Microbial Threats to Support Public Health

 

Monday, April 14th, 13:00 PM

 

Speaker: Univ.-Asst. Gabriela Eder, MSc 

 

Location: Booth #B54

 

Wastewater serves as a mirror of society, offering valuable insights into a wide range of parameters. Molecular biology leverages this potential by regular analysis of wastewater samples to monitor the infection dynamics of various pathogens. In Vienna, respiratory viruses such as SARS-CoV-2, influenza, and RSV have been an integral part of wastewater monitoring for several seasons. Beyond viruses, antibiotic resistance genes of bacteria are of particular interest, as their spread is associated with a major public health threat. In this presentation, the above-mentioned possibilities of molecular biological wastewater monitoring, which are carried out at TU Wien, will be highlighted, and it will be discussed how quantitative analysis of different targets using dPCR can support public health efforts by providing precise and reliable data for infection surveillance and antimicrobial resistance tracking.



Visit our scientific posters

Evaluation of rezafungin on the Thermo Scientific Sensititre YeastOne panel

April 12, 2025, 12:00 - 13:30 in Hall D

Poster number: P2928

Session title: Antifungal susceptibility testing and resistance (incl. surveilance, mechanisms)


Performance evaluation of a novel Candida auris differentiation medium

12:00-13:30 in Hall D


High percent of co-detections of viral versus bacterial gastrointestinal pathogens in stool samples calls for a different approach in analysis of molecular testing results

April 12, 2025, 12:00-13:30 in Hall D

Poster number: P0314

Session title: 01f. Diagnostic virology (other than respiratory viruses, herpesviruses, hepatitis & HIV; incl traditional, molecular, genomic and other methods)


Development and comparative evaluation of antimicrobial resistance quality control materials through absolute quantification using ddPCR and dPCR systems

April 14, 2025, 12:00-13:30 in Hall D

Poster number: P1710

Session title: 03e. Resistance detection/prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)


Products and services featured in the booth

Thermo Scientific Sensititre AST System**

The Sensititre System provides definitive minimum inhibitory concentration (MIC) results and scalable instrumentation options to support laboratories, clinicians, and pharmacists in the fight against antimicrobial resistance. Help clinicians to achieve the best possible clinical outcomes for today’s critically-ill patients and protect new antimicrobials and last-resort therapies for future generations.

QuantStudio 5 Dx Real-Time PCR System**

Providing premium performance at an affordable price, the Applied Biosystems QuantStudio 5 Dx system is designed to fit seamlessly into your existing clinical workflow to help maximize productivity and results.

 

Additionally, Applied Biosystems Diomni Enterprise Software is an on-premise workflow solution that connects all steps in your real-time PCR (qPCR) test development and routine testing workflows with one single ecosystem.

Thermo Scientific Brilliance Chromogenic Culture Media**

Detect, presumptively identify, or screen samples for pathogenic and non-pathogenic organisms with speed and accuracy using Brilliance chromogenic media. Colorful, easy-to-read colonies and short incubation times enable timely and important decision-making for both clinical and food testing laboratories.

Clinical Testing Solutions**

A broad range of reliable and simple PCR-based testing to help diagnosis. The CE-IVD marked Applied Biosystems TaqPath and TaqPath Menu | GeneProof assays facilitate effective molecular diagnostics that help to control and diagnose infectious diseases like RTI, STI, vector borne, blood borne, HIV, transplant-associated and immunocompromised infections.


QuantStudio Absolute Q Digital PCR System*

dPCR enables quantitative detection of DNA and RNA. Environmental surveillance and wastewater-based epidemiology are used to monitor public health threats by testing for specific environmental DNA (eDNA) and RNA (eRNA). Because such targets are often found at low concentration, detection requries sensitive analytical tools. The Applied Biosystems QuantStudio Absolute Q Digital PCR System enables absolute quantification of low-level targets while helping overcome common challenges with environmental samples.

Customized Research Testing Solutions*

Work with us to implement tailored solutions that meet your laboratory’s throughput and business needs. Discover our scalable real-time PCR and digital workflows for volume flexibility.

 

Our qPCR and dPCR solutions are ideal for pathogen detection, microbiome analysis, environmental analysis, pharmacogenomics ID, and ABR gene target. Partner with us to optimize your research and achieve reliable results.

*For Research Use Only. Not for use in diagnostic procedures.

**For In Vitro Diagnostic Use.

Products are distributed globally so uses, applications, and availability of product in each country depend on local regulatory marketing authorization status.